- Home
- IMTX vs HQH Comparison
IMTX vs HQH Comparison
Compare IMTX & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMTX | HQH |
|---|---|---|
| Founded | N/A | 1986 |
| Country | Germany | United States |
| Employees | 407 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMTX | HQH |
|---|---|---|
| Price | $10.91 | $19.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 361.6K | 143.7K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.09 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.91 | N/A |
| P/E Ratio | ★ N/A | $17.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.94 | $14.98 |
| 52 Week High | $12.41 | $20.46 |
Technical Indicators
Market Signals| Indicator | IMTX | HQH |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 66.42 |
| Support Level | $9.66 | $18.61 |
| Resistance Level | $11.30 | $20.46 |
| Average True Range (ATR) | 0.49 | 0.43 |
| MACD | 0.13 | 0.23 |
| Stochastic Oscillator | 88.71 | 95.11 |
Price Performance
Historical ComparisonAbout IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About HQH abrdn Healthcare Investors Shares of Beneficial Interest
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.